We’re pleased to welcome the members of SAATVBR as national society members of EAS. We’re looking forward to them taking part in the life of…
During 2022 EAS issued a Call for applications from National Atherosclerosis and related Societies, with the aim of providing financial support to educational projects that…
After The 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias were released, EAS published The Clinician’s Handbook: Dyslipidaemia and Atherosclerosis Prevention, Diagnosis and Treatment as…
Funding available to support research projects of early-career EAS members One of the aims of the Society is to ensure that research in the atherosclerosis…
EAS Congress: EAS Congress 2023 in Mannheim is about to start! #EASCongress2023 is starting this Sunday. We look forward to welcoming you to the 91st…
EAS Publications: 2023 Update on Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance We are glad to inform you that our Updated…
Gothenburg, May 3, 2023 Homozygous familial hypercholesterolaemia (HoFH), the most severe form of this high cholesterol disorder, affecting about one in 300,000 people, is poorly…
EAS Congress: Invite your network to join you in Mannheim We look forward to welcoming you to the #EASCongress2023 in Mannheim, gathering clinicians and atherosclerosis…
EAS Congress: Less than one month left for the EAS Congress 2023 Unlock your potential at the #EASCongress2023! Join us and stay up-to-date with the…
EAS Academy: Webinar “Update on the impact of nutrition on ASCVD” available on-demand March ended with the excellent Update on the impact of nutrition on ASCVD.…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
